Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YUN BBY is a line of topical probiotic skincare products specifically formulated for infants and babies. Developed by YUN Probiotherapy, the product line utilizes live *Lactobacillus* bacteria as the active ingredient to restore and maintain the skin's natural microbiome balance. The formulation employs a patented micro-encapsulation technology that protects the live bacteria until application, ensuring they remain viable and effective. The primary goal of the BBY range is to repair, protect, and strengthen the skin's protective layer, particularly for sensitive baby skin and conditions like diaper rash, by forming a protective shield of beneficial bacteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on YUN BBY.